VC-backed medical device company Neuronetics debuts IPO
Neuronetics, a medical device company, has gone public after pricing its IPO of 5.5 million shares at $17 per share. The stock began trading on the NASDAQ under the ticker symbol "STIM." Piper Jaffray & Co. and William Blair & Company LLC are the lead underwriters. Neuronetics' pre-IPO backers included Ascension Ventures, Accuitive Medical Ventures, GE Ventures, Interwest Partners, New Leaf Venture Partners, Onset Ventures, Polaris Venture Partners and Three Arch Partners.
28 June 2018•3 mins read
